Interferon signaling in myocardial infarction: mechanistic insights and translational prospects
- 1National Clinical Research Center for TCM Cardiology, Xiyuan Hospital of China Academy of Chinese Medical Sciences
- 2The Second Department of Geriatrics, Xiyuan Hospital of China Academy of Chinese Medical Sciences
- 3Key Laboratory of Disease and Syndrome Integration Prevention and Treatment of Vascular Aging, Xiyuan Hospital of China Academy of Chinese Medical Sciences
Abstract
Inflammation following myocardial infarction (MI) is a key determinant of patient prognosis; however, existing anti-inflammatory strategies remain limited in terms of overall benefit, patient eligibility, and safety, creating an urgent need for the development of new anti-inflammatory approaches. Interferon (IFN) signaling permeates the entire process of inflammation and repair following MI. During the inflammatory phase, the cGAS-STING-mediated IFN-I response promotes inflammatory damage; during the proliferative phase, sustained IFN signaling delays the resolution of inflammation and impedes scar formation, whereas moderate IFN signaling promotes resolution; during the maturation phase, IFN signaling can both limit excessive fibrosis and promote low-grade inflammation, scar instability, and the progression of ischemic heart failure. Therefore, precisely identifying the spatiotemporal windows with clear pathogenic roles is of great significance for the translation of IFN signaling. Compared to the bidirectional effects of IFN signaling during the proliferation and maturation phases, the cGAS-STING axis, with its clearly pro-inflammatory role during the inflammatory phase, holds greater translational potential. The development of tissue-specific cGAS-STING inhibitors based on nanodelivery, restricted to short-term application during the acute inflammatory phase of MI, may offer a new therapeutic direction for post-MI anti-inflammatory strategies. Furthermore, in-depth analysis of IFN signaling in conjunction with clinical cohorts in future studies will further aid in the development of precise immunomodulatory strategies for MI.
Related
- Natural Product-Derived Hydrogels for Myocardial Infarction Repair: Mechanisms, Challenges, and Translational Perspectives
- An Infusible Decellularized Extracellular Matrix Material Binds to Vasculature in Infarcted Myocardium and Induces Pro-Reparative Gene Expression Following Acute Myocardial Infarction Through Inherent Avidity and Bioactive Signaling.
- miR-20a-5p inhibition attenuates post-myocardial infarction ventricular remodeling in association with mTORC1/S6 signaling
- ECG-Derived Synthetic Left Ventricular Mechanics Predict Mortality After Acute Myocardial Infarction and Fatal Myocardial Infarction in the General Population
- Beta-Blocker Therapy After Acute Myocardial Infarction
BibTeX
@article{xu2026interferon,
title = {{Interferon signaling in myocardial infarction: mechanistic insights and translational prospects}},
author = {Shihan Xu and Yanfei Liu and Mengmeng Zhu and Fengqin Xu and Yue Liu},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1914545},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1914545/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Interferon signaling in myocardial infarction: mechanistic insights and translational prospects
AU - Shihan Xu
AU - Yanfei Liu
AU - Mengmeng Zhu
AU - Fengqin Xu
AU - Yue Liu
PY - 2026
DA - 2026/10/09
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1914545
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1914545/full
AB - Inflammation following myocardial infarction (MI) is a key determinant of patient prognosis; however, existing anti-inflammatory strategies remain limited in terms of overall benefit, patient eligibility, and safety, creating an urgent need for the development of new anti-inflammatory approaches. Interferon (IFN) signaling permeates the entire process of inflammation and repair following MI. During the inflammatory phase, the cGAS-STING-mediated IFN-I response promotes inflammatory damage; during the proliferative phase, sustained IFN signaling delays the resolution of inflammation and impedes scar formation, whereas moderate IFN signaling promotes resolution; during the maturation phase, IFN signaling can both limit excessive fibrosis and promote low-grade inflammation, scar instability, and the progression of ischemic heart failure. Therefore, precisely identifying the spatiotemporal windows with clear pathogenic roles is of great significance for the translation of IFN signaling. Compared to the bidirectional effects of IFN signaling during the proliferation and maturation phases, the cGAS-STING axis, with its clearly pro-inflammatory role during the inflammatory phase, holds greater translational potential. The development of tissue-specific cGAS-STING inhibitors based on nanodelivery, restricted to short-term application during the acute inflammatory phase of MI, may offer a new therapeutic direction for post-MI anti-inflammatory strategies. Furthermore, in-depth analysis of IFN signaling in conjunction with clinical cohorts in future studies will further aid in the development of precise immunomodulatory strategies for MI.
SN - 1664-3224
ER -